Vitamin E-based nanomedicines for anti-cancer drug delivery

Journal of Controlled Release

Volumn 182, Issue 1, 2014, Pages 33-44

  Duhem, Nicolas ^a   Danhier, Fabienne ^a   Préat, Véronique ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Anticancer drug; Drug delivery; TOS; TPGS; Vitamin E

Indexed keywords

BIOCHEMISTRY; BIOCOMPATIBILITY; SOLUBILITY;

ACTIVE PHARMACEUTICAL INGREDIENTS; ANTI-CANCER DRUG DELIVERY; ANTICANCER DRUG; BIOLOGICAL PROPERTIES; THERAPEUTIC EFFICIENCY; TOS; TPGS; VITAMIN-E;

DRUG DELIVERY;

ALPHA TOCOPHEROL DERIVATIVE; ALPHA TOCOPHEROL SUCCINATE; ANTINEOPLASTIC AGENT; CAMPTOTHECIN; CISPLATIN; DEOXYCORTICOSTERONE; DOCETAXEL; DOXORUBICIN; EMODIN; EXCIPIENT; GAMBOGIC ACID; LIPOSOME; NANOPARTICLE; PACLITAXEL; PARTHENOLIDE; PRODRUG; QUANTUM DOT; QUERCETIN; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; TOCOFERSOLAN; TOPOTECAN; TRASTUZUMAB; ALPHA TOCOPHEROL;

ANTINEOPLASTIC ACTIVITY; B CELL LYMPHOMA; BIOCOMPATIBILITY; BREAST CANCER; CANCER CHEMOTHERAPY; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG HALF LIFE; DRUG SOLUBILITY; GLIOMA; HUMAN; HYDROPHOBICITY; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; LUNG CANCER; LUNG NON SMALL CELL CANCER; MALIGNANT NEOPLASTIC DISEASE; MELANOMA; MICELLE; NANOMEDICINE; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REVIEW; UTERINE CERVIX CANCER; UTERUS CANCER; ANIMAL; CHEMISTRY; NEOPLASMS;

ANIMALS; ANTINEOPLASTIC AGENTS; DRUG DELIVERY SYSTEMS; HUMANS; NANOMEDICINE; NEOPLASMS; VITAMIN E;

EID: 84896918434     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2014.03.009     Document Type: Review

References (92)

1. L. Plapied, N. Duhem, A. des Rieux, and V. Préat Fate of polymeric nanocarriers for oral drug delivery Curr. Opin. Colloid Interface Sci. 16 2011 228 237
2. O. Farokhzad, and R. Langer Impact of nanotechnology on drug delivery ACS Nano 3 2009 16 20
3. B. Youan Impact of nanoscience and nanotechnology on controlled drug delivery Nanomedicine 3 2008 401 406
4. R. Singh, and J. Lillard Nanoparticle-based targeted drug delivery Exp. Mol. Pathol. 86 2009 215 223
5. J. Hall, M. Dobrovolskaia, A. Patri, and S. McNeil Characterization of nanoparticles for therapeutics Nanomedicine 2 2007 789 803
6. A. Kumari, S. Yadav, and S. Yadav Biodegradable polymeric nanoparticles based drug delivery systems Colloids Surf. B Biointerfaces 75 2010 1 18
7. S. Steichen, M. Caldorera-Moore, and N. Peppas A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics Eur. J. Pharm. Sci. 48 2012 416 427
8. F. Danhier, O. Feron, and V. Preat To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery J. Control. Release 148 2010 135 146
9. S. Bamrungsap, Z. Zhao, T. Chen, L. Wang, C. Li, T. Fu, and W. Tan Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system Nanomedicine 7 2012 1253 1271
10. D. Bharali, M. Khalil, M. Gurbuz, T. Simone, and S. Mousa Nanoparticles and cancer therapy: a concise review with emphasis on dendrimers Int. J. Nanomedicine 4 2009 1 7
11. A. Puri, K. Loomi, B. Smith, J.H. Lee, A. Yavlovich, E. Heldman, and R. Blumenthal Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic Crit. Rev. Ther. Drug Carrier Syst. 26 2009 523 580
12. Z. Zhang, S. Tan, and S. Feng Vitamin E TPGS as a molecular biomaterial for drug delivery Biomaterials 33 2012 4889 4906
13. A. Vaidya, A. Agarwal, A. Jain, R. Agrawal, and S. Jain Bioconjugation of polymers: a novel platform for targeted drug delivery Curr. Pharm. Des. 17 2011 1108 1125
14. M. Vijayakumar, M. Muthu, and S. Singh Copolymers of poly(lactic acid) and d-alpha-tocopheryl polyethylene glycol 1000 succinate-based nanomedicines: versatile multifunctional platforms for cancer diagnosis and therapy Expert Opin. Drug Deliv. 10 2013 529 543
15. R. Petros, and J. DeSimone Strategies in the design of nanoparticles for therapeutic applications Nat. Rev. Drug Discov. 9 2010 615 627
16. M. Davis, Z. Chen, and D. Shin Nanoparticle therapeutics: an emerging treatment modality for cancer Nat. Rev. Drug Discov. 7 2008 771 782
17. R. Jain, and T. Stylianopoulos Delivering nanomedicine to solid tumors Nat. Rev. Clin. Oncol. 7 2010 653 664
18. V. Torchilin Passive and active drug targeting: drug delivery to tumors as an example Handb. Exp. Pharmacol. 2010 3 53
19. D. Mustacich, R. Bruno, and M. Traber Vitamin E Vitam. Horm. 76 2007 1 21
20. R. Wong, and A. Radhakrishnan Tocotrienol research: past into present Nutr. Rev. 70 2012 483 490
21. Y. Guo, J. Luo, S. Tan, B. Otieno, and Z. Zhang The applications of Vitamin E TPGS in drug delivery Eur. J. Pharm. Sci. 49 2013 175 186
22. P. Constantinides, J. Han, and S. Davis Advances in the use of tocols as drug delivery vehicles Pharm. Res. 23 2006 243 255 (Pubitemid 43237855)
23. K. Kline, K. Lawson, W. Yu, and B. Sanders Vitamin E and cancer Vitam. Horm. 76 2007 435 461
24. G. Combs Vitamin E A. Press, The Vitamins Fourth edition 2012 Elsevier 181 211
25. J. Zingg Vitamin E: an overview of major research directions Mol. Aspects Med. 28 2007 400 422 (Pubitemid 47625536)
26. J. Atkinson, T. Harroun, S. Wassall, W. Stillwell, and J. Katsaras The location and behavior of alpha-tocopherol in membranes Mol. Nutr. Food Res. 54 2010 641 651
27. R. Brigelius-Flohe Bioactivity of vitamin E Nutr. Res. Rev. 19 2006 174 186 (Pubitemid 46213349)
28. J. Frank Beyond vitamin E supplementation: an alternative strategy to improve vitamin E status J. Plant Physiol. 162 2005 834 843 (Pubitemid 40772100)
29. A. Azzi, R. Ricciarelli, and J.M. Zingg Non-antioxidant molecular functions of alpha-tocopherol (vitamin E) FEBS Lett. 519 2002 8 10 (Pubitemid 34521983)
30. R. Brigelius-Flohe, F. Kelly, J. Salonen, J. Neuzil, J. Zingg, and A. Azzi The European perspective on vitamin E: current knowledge and future research Am. J. Clin. Nutr. 76 2002 703 716
31. R. Brigelius-Flohe Vitamin E: the shrew waiting to be tamed Free Radic. Biol. Med. 46 2009 543 554
32. K. Prasad, B. Kumar, X. Yan, A. Hanson, and W. Cole Alpha-tocopheryl succinate, the most effective form of vitamin E for adjuvant cancer treatment: a review J. Am. Coll. Nutr. 22 2003 108 117 (Pubitemid 36417824)
33. K. Kline, W. Yu, and B. Sanders Vitamin E and breast cancer J. Nutr. 134 2004 3458S 3462S (Pubitemid 39587590)
34. C. Constantinou, A. Papas, and A. Constantinou Vitamin E and cancer: an insight into the anticancer activities of vitamin E isomers and analogs Int. J. Cancer 123 2008 739 752 (Pubitemid 352032398)
35. Y. Yong-Heng Dong, and Xin-Bin Gu Anticancer mechanisms of vitamin e succinate Chin. J. Cancer 28 2009 1 10
36. J. Zingg Modulation of signal transduction by vitamin E Mol. Aspects Med. 28 2007 481 506 (Pubitemid 47625530)
37. L. Dong, V. Jameson, D. Tilly, L. Prochazka, J. Rohlena, K. Valis, J. Truksa, R. Zobalova, E. Mahdavian, K. Kluckova, and M. Stantic et al. Mitochondrial targeting of alpha-tocopheryl succinate enhances its pro-apoptotic efficacy: a new paradigm for effective cancer therapy Free Radic. Biol. Med. 50 2011 1546 1555
38. V. Anbharasi, N. Cao, and S. Feng Doxorubicin conjugated to d-alpha-tocopheryl polyethylene glycol succinate and folic acid as a prodrug for targeted chemotherapy J. Biomed. Mater. Res. A 94 2010 730 743
39. X. Wang, L. Dong, Y. Zhao, M. Tomasetti, K. Wu, and J. Neuzil Vitamin E analogues as anticancer agents: lessons from studies with alpha-tocopheryl succinate Mol. Nutr. Food Res. 50 2006 675 685 (Pubitemid 44342464)
40. Genentech website http://www.biooncology.com/biological-pathways/ apoptosis/ 2013
41. M. Malafa, and L. Neitzel Vitamin E succinate promotes breast cancer tumor dormancy J. Surg. Res. 93 2000 163 170
42. M. Malafa, F. Fokum, A. Mowlavi, M. Abusief, and M. King Vitamin E inhibits melanoma growth in mice Surgery 131 2002 85 91 (Pubitemid 34118601)
43. K. Barnett, F. Fokum, and M. Malafa Vitamin E succinate inhibits colon cancer liver metastases J. Surg. Res. 106 2002 292 298
44. M. Malafa, F. Fokum, L. Smith, and A. Louis Inhibition of angiogenesis and promotion of melanoma dormancy by vitamin E succinate Ann. Surg. Oncol. 9 2002 1023 1032 (Pubitemid 35424639)
45. J. Neuzil, T. Weber, A. Schroder, M. Lu, G. Ostermann, N. Gellert, G. Mayne, B. Olejnicka, A. Negre-Salvayre, M. Sticha, R. Coffey, and C. Weber Induction of cancer cell apoptosis by alpha-tocopheryl succinate: molecular pathways and structural requirements FASEB J. 15 2001 403 415 (Pubitemid 32141432)
46. M. Stapelberg, N. Gellert, E. Swettenham, M. Tomasetti, P. Witting, A. Procopio, and J. Neuzil Alpha-tocopheryl succinate inhibits malignant mesothelioma by disrupting the fibroblast growth factor autocrine loop: mechanism and the role of oxidative stress J. Biol. Chem. 280 2005 25369 25376 (Pubitemid 40962239)
47. K. Wu, Y. Shan, Y. Zhao, J. Yu, and B. Liu Inhibitory effects of RRR-alpha-tocopheryl succinate on benzo(a)pyrene (B(a)P)-induced forestomach carcinogenesis in female mice World J. Gastroenterol. 7 2001 60 65 (Pubitemid 32170899)
48. L. Ramanathapuram, T. Hahn, M. Graner, E. Katsanis, and E. Akporiaye Vesiculated alpha-tocopheryl succinate enhances the anti-tumor effect of dendritic cell vaccines Cancer Immunol. Immunother. 55 2006 166 177 (Pubitemid 41682588)
49. E. Collnot, C. Baldes, M. Wempe, J. Hyatt, L. Navarro, K. Edgar, U. Schaefer, and C. Lehr Influence of vitamin E TPGS poly(ethylene glycol) chain length on apical efflux transporters in Caco-2 cell monolayers J. Control. Release 111 2006 35 40 (Pubitemid 43289992)
50. T. Bansal, N. Akhtar, M. Jaggi, R. Khar, and S. Talegaonkar Novel formulation approaches for optimising delivery of anticancer drugs based on P-glycoprotein modulation Drug Discov. Today 14 2009 1067 1074
51. E. Collnot, C. Baldes, M. Wempe, R. Kappl, J. Huttermann, J. Hyatt, K. Edgar, U. Schaefer, and C. Lehr Mechanism of inhibition of P-glycoprotein mediated efflux by vitamin E TPGS: influence on ATPase activity and membrane fluidity Mol. Pharm. 4 2007 465 474 (Pubitemid 46983960)
52. H. Youk, E. Lee, M. Choi, Y. Lee, J. Chung, S. Kim, C. Lee, and S. Lim Enhanced anticancer efficacy of alpha-tocopheryl succinate by conjugation with polyethylene glycol J. Control. Release 107 2005 43 52 (Pubitemid 41253701)
53. Y. Yi, J. Kim, H. Kang, S. Oh, S. Kim, and M. Seo A polymeric nanoparticle consisting of mPEG-PLA-Toco and PLMA-COONa as a drug carrier: improvements in cellular uptake and biodistribution Pharm. Res. 22 2005 200 208 (Pubitemid 40487203)
54. S. Noh, S. Han, G. Shim, K. Lee, C. Kim, S. Han, Y. Choi, Y. Kim, W. Kim, and Y. Oh Tocopheryl oligochitosan-based self assembling oligomersomes for siRNA delivery Biomaterials 32 2011 849 857
55. N. Liang, S. Sun, X. Li, H. Piao, H. Piao, F. Cui, and L. Fang Alpha-tocopherol succinate-modified chitosan as a micellar delivery system for paclitaxel: preparation, characterization and in vitro/in vivo evaluations Int. J. Pharm. 423 2012 480 488
56. Y. Tao, J. Han, X. Wang, and H. Dou Nano-formulation of paclitaxel by vitamin E succinate functionalized pluronic micelles for enhanced encapsulation, stability and cytotoxicity Colloids Surf. B Biointerfaces 102 2013 604 610
57. V. Saxena, and M. Hussain Poloxamer 407/TPGS mixed micelles for delivery of gambogic acid to breast and multidrug-resistant cancer Int. J. Nanomedicine 7 2012 713 721
58. L. Zhao, Y. Shi, S. Zou, M. Sun, L. Lil, and G. Zhail Formulation and in vitro evaluation of quercetin loaded polymeric micelles composed of pluronic P123 and d-α-tocopheryl polyethylene glycol succinate J. Biomed. Nanotechnol. 7 2011 358 365
59. Y. Gao, L. Li, and G. Zhai Preparation and characterization of Pluronic/TPGS mixed micelles for solubilization of camptothecin Colloids Surf. B Biointerfaces 64 2008 194 199
60. K. Gill, A. Kaddoumi, and S. Nazzal Mixed micelles of PEG(2000)-DSPE and vitamin-E TPGS for concurrent delivery of paclitaxel and parthenolide: enhanced chemosenstization and antitumor efficacy against non-small cell lung cancer (NSCLC) cell lines Eur. J. Pharm. Sci. 46 2012 64 71
61. J. Wang, J. Sun, Q. Chen, Y. Gao, L. Li, H. Li, D. Leng, Y. Wang, Y. Sun, Y. Jing, S. Wang, and Z. He Star-shape copolymer of lysine-linked di-tocopherol polyethylene glycol 2000 succinate for doxorubicin delivery with reversal of multidrug resistance Biomaterials 33 2012 6877 6888
62. Y. Mi, Y. Liu, and S. Feng Formulation of docetaxel by folic acid-conjugated d-alpha-tocopheryl polyethylene glycol succinate 2000 (Vitamin E TPGS(2K)) micelles for targeted and synergistic chemotherapy Biomaterials 32 2011 4058 4066
63. M. Muthu, S. Kulkarni, A. Raju, and S. Feng Theranostic liposomes of TPGS coating for targeted co-delivery of docetaxel and quantum dots Biomaterials 33 2012 3494 3501
64. M. Muthu, S. Kulkarni, J. Xiong, and S. Feng Vitamin E TPGS coated liposomes enhanced cellular uptake and cytotoxicity of docetaxel in brain cancer cells Int. J. Pharm. 421 2011 332 340
65. T. Wang, X. Yin, Y. Lu, W. Shan, and S. Xiong Formulation, antileukemia mechanism, pharmacokinetics, and biodistribution of a novel liposomal emodin Int. J. Nanomedicine 7 2012 2325 2337
66. Y. Yu, Z. Wang, L. Zhang, H. Yao, Y. Zhang, R. Li, R. Ju, X. Wang, J. Zhou, N. Li, and W. Lu Mitochondrial targeting topotecan-loaded liposomes for treating drug-resistant breast cancer and inhibiting invasive metastases of melanoma Biomaterials 33 2012 1808 1820
67. A. Raju, M. Muthu, and S. Feng Trastuzumab-conjugated vitamin E TPGS liposomes for sustained and targeted delivery of docetaxel Expert Opin. Drug Deliv. 6 2013 747 760
68. J. Shen, Q. Yin, L. Chen, Z. Zhang, and Y. Li Co-delivery of paclitaxel and survivin shRNA by pluronic P85-PEI/TPGS complex nanoparticles to overcome drug resistance in lung cancer Biomaterials 33 2012 8613 8624
69. J. Shen, H. Sun, P. Xu, Q. Yin, Z. Zhang, S. Wang, H. Yu, and Y. Li Simultaneous inhibition of metastasis and growth of breast cancer by co-delivery of twist shRNA and paclitaxel using pluronic P85-PEI/TPGS complex nanoparticles Biomaterials 34 2013 1581 1590
70. Y. Liu, L. Huang, and F. Liu Paclitaxel nanocrystals for overcoming multidrug resistance in cancer Mol. Pharm. 7 2010 863 869
71. M. Shieh, C. Hsu, L. Huang, H. Chen, F. Huang, and P. Lai Reversal of doxorubicin-resistance by multifunctional nanoparticles in MCF-7/ADR cells J. Control. Release 152 2011 418 425
72. N. Song, W. Liu, Q. Tu, R. Liu, Y. Zhang, and J. Wang Preparation and in vitro properties of redox-responsive polymeric nanoparticles for paclitaxel delivery Colloids Surf. B Biointerfaces 87 2011 454 463
73. Z. Zhang, S. Huey Lee, and S. Feng Folate-decorated poly(lactide-co- glycolide)-vitamin E TPGS nanoparticles for targeted drug delivery Biomaterials 28 2007 1889 1899 (Pubitemid 46137995)
74. B. Sun, and S. Feng Trastuzumab-functionalized nanoparticles of biodegradable copolymers for targeted delivery of docetaxel Nanomedicine 4 2009 431 445
75. N. Cao, and S. Feng Doxorubicin conjugated to d-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS): conjugation chemistry, characterization, in vitro and in vivo evaluation Biomaterials 29 2008 3856 3865
76. Y. Mi, J. Zhao, and S. Feng Vitamin E TPGS prodrug micelles for hydrophilic drug delivery with neuroprotective effects Int. J. Pharm. 438 2012 98 106
77. Y. Mi, J. Zhao, and S. Feng Targeted co-delivery of docetaxel, cisplatin and herceptin by vitamin E TPGS-cisplatin prodrug nanoparticles for multimodality treatment of cancer J. Control. Release 169 2013 185 192
78. P. Nielsen, A. Mullertz, T. Norling, and H. Kristensen The effect of alpha-tocopherol on the in vitro solubilisation of lipophilic drugs Int. J. Pharm. 222 2001 217 224 (Pubitemid 32568365)
79. C. Constantinides, P. Koutentis, and J. Schatz A DFT study of the ground state multiplicities of linear vs angular polyheteroacenes J. Am. Chem. Soc. 126 2004 16232 16241 (Pubitemid 39627635)
80. Y. Chan, R. Meyrueix, R. Kravtzoff, F. Nicolas, and K. Lundstrom Review on Medusa:a polymer-based sustained release technology for protein and peptide drugs Expert Opin. Drug Deliv. 4 2007 441 451 (Pubitemid 47249141)
81. Yuehua Zhang, and Lynn C. Gold Tocopherol-Modified Therapeutic Drug Compounds 2007 (US 7,223,770)
82. N. Duhem, F. Danhier, V. Pourcelle, J. Schumers, O. Bertrand, C. Leduff, S. Hoeppener, U. Schubert, J. Gohy, J. Marchand-Brynaert, and V. Préat Self-assembling doxorubicin-tocopherol succinate prodrug as a new drug delivery system: synthesis, characterization, and in vitro and in vivo anticancer activity Bioconjug. Chem. 25 2013 72 81
83. Eastman Eastman Vitamin E TPGS NF Applications and Properties http://www.eastmanexcipients.com 2005
84. E. Collnot, C. Baldes, U. Schaefer, K. Edgar, M. Wempe, and C. Lehr Vitamin E TPGS P-glycoprotein inhibition mechanism: influence on conformational flexibility, intracellular ATP levels, and role of time and site of access Mol. Pharm. 7 2010 642 651
85. OncoGenex Pharmaceuticals website http://ir.oncogenex.com/releasedetail. cfm?ReleaseID=265739 2013
86. Medicalnewstoday website Phase 3 Pivotal Trial Of TOCOSOL(R) Paclitaxel Does Not Meet Primary Endpoint http://www.medicalnewstoday.com/releases/83574. php 2013
87. M. Varma, and R. Panchagnula Enhanced oral paclitaxel absorption with vitamin E-TPGS: effect on solubility and permeability in vitro, in situ and in vivo Eur. J. Pharm. Sci. 25 2005 445 453 (Pubitemid 40853872)
88. Z. Zhang, H. Lv, X. Jia, C. Lingling, J. Xin, C. Yan, X. Tan, and E. Sun Influence of vitamin E tocopherol polyethylene glycol succinate 1000 on intestinal absorption of icariside II Pharmazie 67 2012 59 62
89. M. Muthu, S. Kulkarni, Y. Liu, and S. Feng Development of docetaxel-loaded vitamin E TPGS micelles: formulation optimization, effects on brain cancer cells and biodistribution in rats Nanomedicine 7 2012 353 364
90. H. Rachmawati, L. Al Shaal, R. Muller, and C. Keck Development of curcumin nanocrystal: physical aspects J. Pharm. Sci. 102 2013 204 214
91. L. Mu, and S. Feng A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS J. Control. Release 86 2003 33 48 (Pubitemid 35469120)
92. S. Feng Nanoparticles of biodegradable polymers for cancer treatment Biomaterials 29 2008 4146 4147